Biomarin Pharmaceutical (BMRN) Free Cash Flow (2009 - 2026)
Biomarin Pharmaceutical (BMRN) free cash flow from Jun 30, 2009 to Mar 31, 2026. The TTM Biomarin Pharmaceutical (BMRN) free cash flow is $767M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Biomarin Pharmaceutical (BMRN) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +22.89% |
| 3 Years TTM | +192.00% |
| 5 Years TTM | +46.21% |
Annual Free Cash Flow change of Biomarin Pharmaceutical (BMRN)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | $200M | -72.45% |
| 2025 | $725M | +48.73% |
| 2024 | $487M | +679.00% |
| 2023 | $63M | +13.89% |
| 2022 | $55M | -73.71% |
| 2021 | $209M | -822.05% |
| 2020 | -$29M | -70.09% |
| 2019 | -$97M | -22.22% |
| 2018 | -$124M | +143.70% |
| 2014 | -$51M | -39.07% |
| 2013 | -$84M | +210.76% |
| 2012 | -$27M | -50.50% |
| 2011 | -$54M | +77.37% |
| 2010 | -$31M | +1383.57% |
| 2009 | -$2.07M | -96.84% |
| 2008 | -$66M | N/A |
Comparison Biomarin Pharmaceutical (BMRN) five years free cash flow CAGR with competitors
Biomarin Pharmaceutical (BMRN) five years free cash flow CAGR is 46.21%.